Smad4 antibody | knockout validation | Cell Signaling 38454

This is a knockout-validated antibody summary, based on the publication "Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett's Esophagus", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Smad4 antibody | knockout validation | Cell Signaling 38454 figure 1
Figure 1. Western blot of SMAD4 protein expression levels in CP-B SMAD4 sgRNA clonal populations Ex1 and Ex2 compared to Cas9 only control cells. From [1].
Antibody information

Rabbit monoclonal IgG

Company: Cell Signaling

Antibody: Smad4

Catalog number: 38454

Summary: Rabbit monoclonal antibody against a synthetic peptide corresponding to residues surrounding Asp165 of human SMAD4 protein. Reacts with human, mouse, rat, and monkey. It is predicted to react based on 100% sequence homology with dog, horse, and guinea pig. Suitable for western blot, immunoprecipitation, and Chromatin IP.

Validation Method

Western blot

Sample

Control and SMAD4-KO CP-B cells.

Blocking agent

5% (w/v) skim milk dissolved in Tris-buffered saline (TBS) containing 0.1% (v/v) Tween 20 for 1 hour.

Primary incubation

Overnight at 4°C

Secondary incubation

Swine anti-rabbit HRP secondary antibody (Agilent Technologies, P0217) for 1 hour at room temperature.

Detection

Western Lightning Enhanced Chemiluminescence (PerkinElmer, Billerica, MA) or ECL Plus Western blot substrate kits (Thermo Scientific, Scoresby, Australia).

References
  1. Gotovac J, Kader T, Milne J, Fujihara K, Lara Gonzalez L, Gorringe K, et al. Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett's Esophagus. Cell Mol Gastroenterol Hepatol. 2021;12:689-713 pubmed publisher